Viveve Medical (VIVE) Files Patent Infringement Lawsuit Against Thermi in Texas

October 21, 2016 4:05 PM EDT
Get Alerts VIVE Hot Sheet
Trade VIVE Now!
Join SI Premium – FREE

Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.

Viveve Medical, Inc.'s (NASDAQ: VIVE) wholly-owned subsidiary, Viveve, Inc. ("Viveve"), a medical technology company focused on women's health, today filed a patent infringement lawsuit against ThermiGen, LLC, ThermiAesthetics, LLC, and Dr. Red Alinsod in U.S. District Court for the Eastern District of Texas. The lawsuit seeks redress for the Defendants' unauthorized use of Viveve's patented technology. The action is intended to protect Viveve's significant investment in reverse-thermal gradient radiofrequency technology and its clinical application to tightening vaginal tissue. Viveve is pursuing all available remedies, including an injunction to prevent the Defendants from selling, training, and promoting its infringing products and treatment methods.

The lawsuit is based on U.S. Patent No. 8,961,511 entitled "Vaginal Remodeling Device and Methods." The patent covers methods for remodeling tissue of the vagina and vulva by applying heat to the target tissue. ThermiGen, LLC, ThermiAesthetics, LLC, and Dr. Red Alinsod are accused of willfully infringing Viveve's patent.

"Viveve has invested heavily in our technology and patents. We intend to monitor activities and vigorously protect our intellectual property estate as needed," said Patricia Scheller, chief executive officer of Viveve.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Corporate News, Litigation, Management Comments

Add Your Comment